Bio-Connect
IHC-P analysis of human kidney tissue using GTX46748 G6PC antibody at 5microg/ml.
IHC-P analysis of human kidney tissue using GTX46748 G6PC antibody at 5microg/ml.
IHC-P analysis of human kidney tissue using GTX46748 G6PC antibody at 5microg/ml.

G6PC antibody, N-term

GTX46748
GeneTex
ApplicationsWestern Blot, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
Product group Antibodies
ReactivityHuman
TargetG6PC1
Sign in to order and to see your custom pricing.
Large volume orders?
Order with a bulk request

Overview

  • Supplier
    GeneTex
  • Product Name
    G6PC antibody, N-term
  • Delivery Days Customer
    9
  • Application Supplier Note
    WB: 0.2-2.5 ug/ml. IHC-P: 2-10 ug/ml. *Optimal dilutions/concentrations should be determined by the researcher.Not tested in other applications.
  • Applications
    Western Blot, ImmunoHistoChemistry, ImmunoHistoChemistry Paraffin
  • Certification
    Research Use Only
  • Clonality
    Polyclonal
  • Concentration
    0.5-1 mg/ml
  • Conjugate
    Unconjugated
  • Gene ID2538
  • Target name
    G6PC1
  • Target description
    glucose-6-phosphatase catalytic subunit 1
  • Target synonyms
    G6Pase; G-6-Pase; G6Pase-alpha; G6PC; G6PT; glucose-6-phosphatase alpha; glucose-6-phosphatase catalytic subunit 1; GSD1; GSD1a
  • Host
    Rabbit
  • Isotype
    IgG
  • Protein IDP35575
  • Protein Name
    Glucose-6-phosphatase
  • Scientific Description
    Glucose-6-phosphatase (G6Pase) is a multi-subunit integral membrane protein of the endoplasmic reticulum that is composed of a catalytic subunit and transporters for G6P, inorganic phosphate, and glucose. This gene (G6PC) is one of the three glucose-6-phosphatase catalytic-subunit-encoding genes in human: G6PC, G6PC2 and G6PC3. Glucose-6-phosphatase catalyzes the hydrolysis of D-glucose 6-phosphate to D-glucose and orthophosphate and is a key enzyme in glucose homeostasis, functioning in gluconeogenesis and glycogenolysis. Mutations in this gene cause glycogen storage disease type I (GSD1). This disease, also known as von Gierke disease, is a metabolic disorder characterized by severe hypoglycemia associated with the accumulation of glycogen and fat in the liver and kidneys.[provided by RefSeq, Feb 2011]
  • Reactivity
    Human
  • Storage Instruction
    -20°C or -80°C,2°C to 8°C
  • UNSPSC
    12352203

References

  • MicroRNA-130a can inhibit hepatitis B virus replication via targeting PGC1alpha and PPARgamma. Huang JY et al., 2015 Mar, RNA
    Read more